230 related articles for article (PubMed ID: 26183988)
1. Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development.
Moyakine AV; Hermans DJ; Fuijkschot J; van der Vleuten CJ
J Am Acad Dermatol; 2015 Aug; 73(2):341-2. PubMed ID: 26183988
[No Abstract] [Full Text] [Related]
2. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
3. Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting.
Fogel I; Ollech A; Zvulunov A; Valdman-Greenshpon Y; Atar Snir V; Friedland R; Lapidoth M; Ben-Amitai D
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):2004-2009. PubMed ID: 29573481
[TBL] [Abstract][Full Text] [Related]
4. A new treatment pathway for propranolol use in infantile haemangiomas.
May JE; Liew SH
J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):e91-2. PubMed ID: 24268691
[No Abstract] [Full Text] [Related]
5. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
6. Successful first-line treatment with propranolol of multifocal infantile hepatic hemangioma with high-flow cardiac overload.
Sciveres M; Marrone G; Pipitone S; Riva S; Spada M; Gridelli B; Maggiore G
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):693-5. PubMed ID: 21519284
[No Abstract] [Full Text] [Related]
7. Update on infantile hemangiomas.
Lee KC; Bercovitch L
Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
[TBL] [Abstract][Full Text] [Related]
8. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
[TBL] [Abstract][Full Text] [Related]
9. Nonsurgical treatment of two cases of infantile facial growths in a resource-poor setting.
Natawidjaja R; Ewen Wang N
Wilderness Environ Med; 2015 Mar; 26(1):91-3. PubMed ID: 25712300
[No Abstract] [Full Text] [Related]
10. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
11. PHACE syndrome, a series of six patients: clinical and morphological manifestations, propranolol efficacy, and safety.
Bellaud G; Puzenat E; Billon-Grand NC; Humbert P; Aubin F
Int J Dermatol; 2015 Jan; 54(1):102-7. PubMed ID: 24962639
[TBL] [Abstract][Full Text] [Related]
12. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
Vassallo P; Forte R; Di Mezza A; Magli A
Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870
[TBL] [Abstract][Full Text] [Related]
13. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers.
Martin K; Blei F; Chamlin SL; Chiu YE; Frieden IJ; Frommelt PC; Garzon MC; Kwon EK; MacLellan-Tobert S; Mancini AJ; Seefeldt M; Sidbury R; Siegel DH; Drolet BA; Boucek RJ
Pediatr Dermatol; 2013; 30(1):155-9. PubMed ID: 23316721
[TBL] [Abstract][Full Text] [Related]
14. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
[TBL] [Abstract][Full Text] [Related]
15. Propranolol in the management of infantile hemangiomas: clinical response and predictors.
Balma-Mena A; Chakkittakandiyil A; Weinstein M; Lansang P; Ho N; Cammisuli S; Pope E
J Cutan Med Surg; 2012; 16(3):169-73. PubMed ID: 22713439
[TBL] [Abstract][Full Text] [Related]
16. Patient Perspectives: Propranolol for infantile hemangiomas.
Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
[No Abstract] [Full Text] [Related]
17. Treatment with propranolol for infantile hemangiomas: single-center experience.
Turhan AB; Bör Ö; Özdemir ZC
J Cosmet Dermatol; 2016 Sep; 15(3):296-302. PubMed ID: 27061310
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
[TBL] [Abstract][Full Text] [Related]
19. Eighteen cases of soft tissue atrophy after intralesional bleomycin a5 injections for the treatment of infantile hemangiomas: a long-term follow-up.
Qiu Y; Lin X; Ma G; Chang L; Jin Y; Chen H; Hu X
Pediatr Dermatol; 2015; 32(2):188-91. PubMed ID: 25640925
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Infantile Haemangioma - Perspective of a Regional Surgical Centre.
Ho W; Hoo C; Black C
Ulster Med J; 2019 May; 88(2):102-104. PubMed ID: 31061558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
